Edoxaban cas: 480449-70-5 is a pharmaceutical drug that is used to prevent blood clots in patients who are at risk of clotting. This drug belongs to the class of drugs known as anticoagulants, which work by interfering with the blood's ability to clot. Edoxaban has been scientifically studied for its potential therapeutic uses and has been found to offer a range of health benefits.
Chemical Name:
The chemical name for Edoxaban cas: 480449-70-5 is (1R,2S,3R,4S,5S,6R)-5-[(4-amino-2-oxo-2H-pyridin-1-yl)methyl]-4-hydroxy-6-[(1S)-1-hydroxyethyl]-3-{[(2S)-2-{[(2S)-1-(2-oxoethyl)-3-piperidyl]oxy}propanoyl]amino}-2-methylpen-tan-2-yl 7-fluoro-2-oxo-4-propyl-1,2,3,4-tetrahydroquinoline-3-carboxylate.
Molecular Formula:
The molecular formula for Edoxaban is C24H30FN7O4S.
Formula Weight:
The formula weight for this drug is 548.646 g/mol.
CAS No:
Edoxaban cas: 480449-70-5 is the CAS No (Chemical Abstracts Service Number) for this drug.
Top Ten Keywords and Synonyms:
Health Benefits of this Product:
Edoxaban has been found to offer several health benefits. The primary use of this medication is to prevent blood clots in patients who are at risk of clotting. Some of the other potential health benefits of this drug include:
Prevention of stroke: Edoxaban is used to reduce the risk of stroke in patients with nonvalvular atrial fibrillation.
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE): Edoxaban is also used to treat DVT and PE in certain patients.
Warfarin alternative: Edoxaban is an alternative to warfarin, a commonly used anticoagulant, which requires more frequent monitoring and dietary restrictions.
Potential Effects:
Edoxaban can have both beneficial and harmful effects. Some of the potential effects of this medication include:
Bleeding: Like other anticoagulants, Edoxaban can increase the risk of bleeding, which can be serious or life-threatening.
Interactions with other medications: Edoxaban can interact with other medications, including prescription and over-the-counter drugs, as well as herbal supplements.
Renal insufficiency: Edoxaban can cause renal insufficiency in patients with pre-existing kidney disease.
Increased risk of thrombosis: In rare cases, Edoxaban can increase the risk of thrombosis, particularly in patients with a history of thrombosis or in those with certain medical conditions.
Product Mechanism:
Edoxaban is a factor Xa inhibitor that works by blocking the enzyme factor Xa, which plays a critical role in the formation of blood clots. By inhibiting factor Xa, Edoxaban can reduce the risk of thromboembolism and other serious medical conditions.
Safety:
Edoxaban, like all medications, carries some risk of adverse effects. It is important for patients to discuss their medical history, current medications, and all other healthcare concerns with their healthcare provider before beginning treatment with Edoxaban.
Side Effects:
Some of the most commonly reported side effects of Edoxaban include bleeding, headache, nausea, fatigue, and dizziness. Patients who experience any of these side effects or who develop other symptoms should contact their healthcare provider immediately.
Dosing Information:
Edoxaban is typically taken orally and is dosed based on the patient's weight, medical history, and the indication for treatment. Patients should receive regular monitoring of their blood clotting status to ensure that the medication is effective and that the patient is not experiencing any adverse effects.
Conclusion:
Edoxaban is a medication that has been found to offer several health benefits, particularly in patients who are at risk of thromboembolism or who have nonvalvular atrial fibrillation. As with all medications, it is important for patients to discuss their healthcare concerns with their healthcare provider and to follow all dosing instructions to ensure safe and effective treatment
